Jeffrey W. Albers insider trades: Spyre Therapeutics (SYRE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
65 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | SYRE | ↓ Sell | 18,000 | $104.55 | $1.9M | By Sessions LLC | Aug 10, 2026 (3d) |
| Aug 7, 2026 | SYRE | ↓ Sell | 5,000 | $104.47 | $522K | Direct | Aug 10, 2026 (3d) |
| Dec 8, 2025 | KYMR | ↓ Sell | 5,000 | $89.76 | $449K | Direct | Dec 8, 2025 (0d) |
| Oct 13, 2025 | KYMR | ↓ Sell | 5,000 | $59.19 | $296K | Direct | Oct 14, 2025 (1d) |
| Jun 3, 2025 | KYMR | ↓ Sell | 6,349 | $49.00 | $311K | Direct | Jun 3, 2025 (0d) |
| May 27, 2025 | BPMC | ↓ Sell | 5,000 | $101.14 | $506K | Direct | May 29, 2025 (2d) |
| Mar 12, 2025 | BPMC | ↓ Sell | 7,500 | $87.80 | $659K | Direct | Mar 14, 2025 (2d) |
| Mar 5, 2025 | BPMC | ↓ Sell | 5,766 | $88.80 | $512K | Direct | Mar 17, 2025 (12d) |
| Jan 21, 2025 | BPMC | ↓ Sell | 15,161 | $109.53 | $1.7M | Direct | Jan 23, 2025 (2d) |
| Jan 13, 2025 | BPMC | ↓ Sell | 5,000 | $102.28 | $511K | Direct | Jan 15, 2025 (2d) |
| Dec 19, 2024 | BPMC | ↓ Sell | 15,000 | $89.77 | $1.3M | Direct | Dec 20, 2024 (1d) |
| Nov 7, 2024 | BPMC | ↓ Sell | 5,000 | $102.00 | $510K | Direct | Nov 12, 2024 (5d) |
| Nov 6, 2024 | SYRE | ↓ Sell | 6,700 | $36.76 | $246K | By Sessions LLC | Nov 8, 2024 (2d) |
| Oct 25, 2024 | SYRE | ↓ Sell | 300 | $36.43 | $11K | By Sessions LLC | Oct 28, 2024 (3d) |
| Sep 9, 2024 | BPMC | ↓ Sell | 19,702 | $85.57 | $1.7M | Direct | Sep 11, 2024 (2d) |
| Aug 26, 2024 | KYMR | ↓ Sell | 5,000 | $49.10 | $246K | Direct | Aug 26, 2024 (0d) |
| Mar 20, 2024 | BPMC | ↓ Sell | 25,073 | $87.28 | $2.2M | Direct | Mar 22, 2024 (2d) |
| Mar 7, 2024 | BPMC | ↓ Sell | 11,033 | $90.69 | $1.0M | Direct | Mar 26, 2024 (19d) |
| Feb 21, 2024 | KYMR | ↓ Sell | 5,000 | $39.05 | $195K | Direct | Feb 21, 2024 (0d) |
| Jan 25, 2024 | BPMC | ↓ Sell | 25,000 | $81.91 | $2.0M | Direct | Jan 29, 2024 (4d) |
| Jan 23, 2024 | KYMR | ↓ Sell | 10,000 | $30.05 | $300K | Direct | Jan 23, 2024 (0d) |
| Dec 11, 2023 | BPMC | ↓ Sell | 5,000 | $79.07 | $395K | Direct | Dec 13, 2023 (2d) |
| Nov 30, 2023 | BPMC | ↓ Sell | 5,000 | $70.55 | $353K | Direct | Dec 4, 2023 (4d) |
| Nov 24, 2023 | BPMC | ↓ Sell | 15,000 | $67.51 | $1.0M | Direct | Nov 28, 2023 (4d) |
| Nov 3, 2023 | BPMC | ↓ Sell | 10,000 | $60.20 | $602K | Direct | Nov 3, 2023 (0d) |
| Sep 28, 2023 | BPMC | ↓ Sell | 25,000 | $49.76 | $1.2M | Direct | Sep 29, 2023 (1d) |
| Aug 25, 2023 | BPMC | ↓ Sell | 25,000 | $49.81 | $1.2M | Direct | Aug 28, 2023 (3d) |
| Mar 6, 2023 | BPMC | ↓ Sell | 9,793 | $45.67 | $447K | Direct | Mar 8, 2023 (2d) |
| Dec 5, 2022 | BPMC | ↓ Sell | 20,000 | $50.09 | $1.0M | Direct | Dec 7, 2022 (2d) |
| Aug 22, 2022 | BPMC | ↓ Sell | 10,000 | $70.45 | $705K | Direct | Aug 23, 2022 (1d) |
| Aug 16, 2022 | BPMC | ↓ Sell | 20,000 | $68.41 | $1.4M | Direct | Aug 18, 2022 (2d) |
| Aug 8, 2022 | BPMC | ↓ Sell | 10,000 | $70.07 | $701K | Direct | Aug 10, 2022 (2d) |
| May 16, 2022 | BPMC | ↓ Sell | 20,000 | $55.89 | $1.1M | Direct | May 18, 2022 (2d) |
| Apr 6, 2022 | BPMC | ↓ Sell | 5,000 | $70.11 | $351K | Direct | Apr 8, 2022 (2d) |
| Mar 7, 2022 | BPMC | ↓ Sell | 32,705 | $57.90 | $1.9M | Direct | Mar 8, 2022 (1d) |
| Nov 15, 2021 | BPMC | ↓ Sell | 30,000 | $114.50 | $3.4M | Direct | Nov 17, 2021 (2d) |
| Nov 1, 2021 | BPMC | ↓ Sell | 5,000 | $115.16 | $576K | Direct | Nov 3, 2021 (2d) |
| Aug 19, 2021 | BPMC | ↓ Sell | 25,000 | $92.68 | $2.3M | Direct | Aug 23, 2021 (4d) |
| May 12, 2021 | BPMC | ↓ Sell | 25,000 | $92.69 | $2.3M | Direct | May 14, 2021 (2d) |
| Mar 4, 2021 | BPMC | ↓ Sell | 18,986 | $89.28 | $1.7M | Direct | Mar 5, 2021 (1d) |
| Dec 14, 2020 | BPMC | ↓ Sell | 5,000 | $119.18 | $596K | Direct | Dec 16, 2020 (2d) |
| Nov 16, 2020 | BPMC | ↓ Sell | 20,000 | $98.71 | $2.0M | Direct | Nov 18, 2020 (2d) |
| Oct 7, 2020 | BPMC | ↓ Sell | 5,000 | $99.17 | $496K | Direct | Oct 9, 2020 (2d) |
| Aug 19, 2020 | BPMC | ↓ Sell | 20,000 | $75.02 | $1.5M | Direct | Aug 21, 2020 (2d) |
| May 12, 2020 | BPMC | ↓ Sell | 20,000 | $64.67 | $1.3M | Direct | May 14, 2020 (2d) |
| Mar 23, 2020 | BPMC | ↓ Sell | 20,000 | $52.10 | $1.0M | Direct | Mar 25, 2020 (2d) |
| Mar 9, 2020 | BPMC | ↓ Sell | 2,277 | $51.97 | $118K | Direct | Mar 11, 2020 (2d) |
| Nov 18, 2019 | BPMC | ↓ Sell | 20,000 | $74.91 | $1.5M | Direct | Nov 20, 2019 (2d) |
| Aug 19, 2019 | BPMC | ↓ Sell | 20,000 | $81.73 | $1.6M | Direct | Aug 21, 2019 (2d) |
| Jun 17, 2019 | BPMC | ↓ Sell | 5,000 | $99.06 | $495K | Direct | Jun 19, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SYRE insiders
Open-market trades in the last 12 months
About Jeffrey W. Albers's insider trades
Jeffrey W. Albers is a director at Spyre Therapeutics (SYRE). Since Nov 2, 2015, Jeffrey has reported no open-market purchases and 65 sales worth $66.9M on SEC Form 4. In the last 12 months: 3 sales ($2.9M).
Their filings also include option exercises (53 filings), grants and awards (24 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SYRE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.